-
Product Insights
Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Nuclear Imaging Equipment Pipeline Market Report Overview Nuclear Imaging Equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. The nuclear imaging equipment...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Sector Analysis
Americas Fibercos and Towercos Market Dynamics and Opportunities
Americas Fibercos and Towercos Market Report Overview Proliferation of 5G deployments in the Americas (mostly in North America) will require significant investment in telecom infrastructure, both in towers and fiber. Considering these investment and coverage imperatives in 5G and FTTH/B, telcos are turning to fibercos and towercos to spur network expansion and asset monetization. Capex reduction and asset monetization are key drivers for telcos to consider opportunities in towercos and fibercos. The Americas Fibercos and Towercos market research report reviews...
-
Product Insights
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018" provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inflammatory Disease (Pelvic Infections). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Precocious Puberty Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Precocious Puberty Global Clinical Trials Review, H1, 2018" provides an overview of Precocious Puberty clinical trials scenario. This report provides top line data relating to the clinical trials on Precocious Puberty. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Gaucher Disease Type I Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Gaucher Disease Type I Global Clinical Trials Review, H2, 2017" provides an overview of Gaucher Disease Type I clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease Type I. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and an increase in deal values in April 2017. The industry reported 289 deals worth USD26.9 billion in April 2017, compared to 402 deals worth USD17.8 billion in March 2017. The oncology therapeutics market remained at the top in deal activity in April 2017 with 96 deals. In second place, CNS therapeutics market reported 70 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in...
-
Product Insights
Brain Hemorrhage Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H1, 2017" provides an overview of Brain Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2017" provides an overview of Intracerebral Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Intracerebral Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...